CORMORANT ASSET MANAGEMENT, LLC Information

200 CLARENDON STREET, BOSTON, Massachusetts, 02116, (617) 848-3429

Report Date: 06/30/2015

Position Statistics

Total Positions 85
New Positions 15
Increased Positions 35
Decreased Positions 17
Positions with Activity 52
Sold Out Positions 7
Total Mkt Value (in $ millions) 659

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 57.68%
Services
Technology
Transportation
Utilities

15 New Positions as of 06/30/2015

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
ALNYLAM PHARMACEUTICALS INC COM 14,407 14,407 New 140,000
DYNAVAX TECHNOLOGIES CORP COM NEW 14,180 14,180 New 500,000
COLLEGIUM PHARMACEUTICAL INC COM 6,804 6,804 New 450,000
CELYAD SA ADR 3,659 3,659 New 75,000
AMICUS THERAPEUTICS INC COM 2,876 2,876 New 200,000
BLUEPRINT MEDICINES CORP COM 2,736 2,736 New 100,000
AVEO PHARMACEUTICALS INC COM 2,175 2,175 New 1,587,715
SERES THERAPEUTICS INC COM 2,067 2,067 New 50,000
ATARA BIOTHERAPEUTICS INC COM 2,027 2,027 New 50,000
CONTRAFECT CORP COM 1,151 1,151 New 234,406
HTG MOLECULAR DIAGNOSTICS INC COM 1,120 1,120 New 201,000
PROVECTUS BIOPHARMACEUTICALS I COM 913 913 New 2,200,000
BIOTIE THERAPIES OYJ SPONSORED ADR 851 851 New 50,000
PROVECTUS BIOPHARMACEUTICALS I WT EXP 062420 550 550 New 2,200,000
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR 274 274 New 25,000